Physician

Abhishek Agarwal, MD

According to 2025 Medicare claims, Abhishek Agarwal, MD (NPI: 1417365438) practices pulmonary disease in the Camden, NJ market, with the plurality of this provider's patient population coming from Camden, NJ. This provider's primary affiliated billing organization is VIRTUA MEDICAL GROUP, PA (NPI: 1649226515; TIN: 271348772) and primary practice location at 08103-3101. Agarwal is affiliated with the Bayview Physicians Group (ACO ID: A2308), participating under the MSSP model.

Agarwal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 597 traditional Medicare patients, billed 1,461 HCPCS/CPT codes, and received $136,885 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 443 prescription claims across 146 beneficiaries totaling $216,563 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 1,436 claims. Open Payments data shows 33 records totaling $651. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, reported payments did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	333	1,139	$88,473
2021	576	2,619	$234,036
2022	494	1,934	$162,349
2023	516	1,310	$135,816
2024	597	1,461	$136,885

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	79	202	$44,738
2021	143	844	$343,950
2022	139	687	$356,699
2023	120	544	$276,158
2024	146	443	$216,563

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	350	1,143	$173,411
2022	407	1,570	$182,839
2023	475	1,854	$208,435
2024	418	1,436	$132,382

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	104	104	$139
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	81	82	$106
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	196	440	$96
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	95	107	$85
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	177	307	$65

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	67	2,670	$56,212
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	27	1,290	$26,167
Breo Ellipta	Fluticasone/Vilanterol	13	450	$5,903
Fluticasone Propionate	Fluticasone Propionate	63	3,510	$945
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	570	$895

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	45	$45,344
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	28	233	$19,695
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	22	$16,613
E1392	Portable oxygen concentrator, rental	Y	21	170	$6,114
A7031	Face mask interface, replacement for full face mask, each	N	30	61	$5,633

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	33	$651	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abhishek Agarwal, MD?

Tedicare shows public-source Medicare data for Abhishek Agarwal, MD (NPI 1417365438), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abhishek Agarwal, MD have ACO affiliation data?

Abhishek Agarwal, MD is shown with ACO affiliation data for Bayview Physicians Group (MSSP, ACO ID A2308).

What billing organization is linked to Abhishek Agarwal, MD?

Abhishek Agarwal, MD is linked to VIRTUA MEDICAL GROUP, PA (billing NPI 1649226515) in the available physician profile data.

Does Abhishek Agarwal, MD have Open Payments data?

Abhishek Agarwal, MD has 33 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.